Aggregation of lipid rafts activates c-met and c-Src in non-small cell lung cancer cells | BMC Cancer | Full Text
Tyrosine Kinase Assay Kits | MBL Life Sience -ASIA-
Dual inhibition of MET and SRC kinase activity as a combined targeting strategy for colon cancer
An overview of the c-MET signaling pathway. - Abstract - Europe PMC
c-MET/HGF pathway. Abbreviations: HGF, hepatocyte growth factor; PI3K,... | Download Scientific Diagram
C-Met - Wikipedia
Understanding and Targeting MET Signaling in Solid Tumors - Are We There Yet?
PLOS ONE: Hepatocyte Growth Factor Increases Osteopontin Expression in Human Osteoblasts through PI3K, Akt, c-Src, and AP-1 Signaling Pathway
Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET | PNAS
c-MET signaling adaptors and mediators. When the tyrosines within the... | Download Scientific Diagram
c-MET in Head and Neck Squamous Cell Carcinoma | SpringerLink
EGFR is physically associated with distinct Src family kinases, c-Met,... | Download Scientific Diagram
KAI1/CD82 suppresses the activity of Src via its upstream activator.... | Download Scientific Diagram
Targeting Src in breast cancer - ScienceDirect
Products: MET Turbochargers | Mitsubishi Heavy Industries Marine Machinery & Equipment Co.,Ltd.
Src as a potential therapeutic target in non-small-cell lung cancer - Annals of Oncology
IJMS | Free Full-Text | Cetuximab-Induced MET Activation Acts as a Novel Resistance Mechanism in Colon Cancer Cells | HTML
Distinct Interactions Between c-Src and c-Met in Mediating Resistance to c- Src Inhibition in Head and Neck Cancer | Clinical Cancer Research
PLOS ONE: Combined Inhibition of IGF-1R/IR and Src Family Kinases Enhances Antitumor Effects in Prostate Cancer by Decreasing Activated Survival Pathways
Figure 2 from The molecular effect of metastasis suppressors on Src signaling and tumorigenesis: new therapeutic targets | Semantic Scholar
Hepatocyte growth factor (HGF) binding c-Met activates signaling... | Download Scientific Diagram
Distinct Interactions Between c-Src and c-Met in Mediating Resistance to c- Src Inhibition in Head and Neck Cancer | Clinical Cancer Research
Dual inhibition of MET and SRC kinase activity as a combined targeting strategy for colon cancer
Crizotinib inhibits migration and expression of ID1 in MET-positive lung cancer cells: implications for MET targeting in oncology | Future Oncology
CUB domain-containing protein 1 controls HGF responses by integrating Src and Met–STAT3 signaling | bioRxiv
